ES2388094B1 - Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension. - Google Patents

Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension.

Info

Publication number
ES2388094B1
ES2388094B1 ES201130260A ES201130260A ES2388094B1 ES 2388094 B1 ES2388094 B1 ES 2388094B1 ES 201130260 A ES201130260 A ES 201130260A ES 201130260 A ES201130260 A ES 201130260A ES 2388094 B1 ES2388094 B1 ES 2388094B1
Authority
ES
Spain
Prior art keywords
hypertension
treatment
molecular weight
lactoferrine
hydrolyze
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn - After Issue
Application number
ES201130260A
Other languages
English (en)
Other versions
ES2388094A1 (es
Inventor
Mir Paloma Manzanares
Alventosa Salvador Valles
Lopez Jose F Marcos
Sanchez Isidra Recio
Pedro Ruiz-Gimenez
Bernabe German Torregrosa
Dominguez Enrique Alborch
Sanvalero Juan B Salom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Fundacion para la Investigacion del Hospital Universitario y Politecnico La Fe de La Comunidad Valenciana
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Fundacion para la Investigacion del Hospital Universitario y Politecnico La Fe de La Comunidad Valenciana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Fundacion para la Investigacion del Hospital Universitario y Politecnico La Fe de La Comunidad Valenciana filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES201130260A priority Critical patent/ES2388094B1/es
Priority to PCT/ES2012/070056 priority patent/WO2012117136A1/es
Publication of ES2388094A1 publication Critical patent/ES2388094A1/es
Application granted granted Critical
Publication of ES2388094B1 publication Critical patent/ES2388094B1/es
Withdrawn - After Issue legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES201130260A 2011-02-28 2011-02-28 Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension. Withdrawn - After Issue ES2388094B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201130260A ES2388094B1 (es) 2011-02-28 2011-02-28 Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension.
PCT/ES2012/070056 WO2012117136A1 (es) 2011-02-28 2012-01-31 Fracción de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertensión

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201130260A ES2388094B1 (es) 2011-02-28 2011-02-28 Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension.

Publications (2)

Publication Number Publication Date
ES2388094A1 ES2388094A1 (es) 2012-10-08
ES2388094B1 true ES2388094B1 (es) 2013-09-13

Family

ID=46757387

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201130260A Withdrawn - After Issue ES2388094B1 (es) 2011-02-28 2011-02-28 Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension.

Country Status (2)

Country Link
ES (1) ES2388094B1 (es)
WO (1) WO2012117136A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321358B1 (es) * 2006-04-05 2010-03-05 Consejo Susperior De Investigaciones Cientificas Uso de peptidos derivados de la lactoferrina para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i.
EP2253324A1 (en) * 2009-04-30 2010-11-24 Consejo Superior De Investigaciones Cientificas Use of a casein-derived peptide and compositions thereof as antihypertensive

Also Published As

Publication number Publication date
ES2388094A1 (es) 2012-10-08
WO2012117136A1 (es) 2012-09-07

Similar Documents

Publication Publication Date Title
MX2014015423A (es) Analogos de peptido de exedina-4.
EA201991293A1 (ru) Получение новых препаратов на основе бета-лактоглобулина и связанные с ними способы, варианты применения и продукты питания
CO7151525A2 (es) Proteínas del factor 21 de crecimiento del fibroblasto
UY33739A (es) Metodos de tratamiento de trastornos asociados con el fgf21
PH12015502102B1 (en) Reducing proinflammatory response
MX2018012056A (es) Composiciones farmaceuticas y alimenticias basadas en hafnia alvei para inducir la saciedad y prolongar la saciedad.
EA201890815A1 (ru) Аминокислотные композиции с модифицированным высвобождением для перорального введения
BR112017014580A8 (pt) Método para obter um isolado peptídico a partir de uma biomassa de microalgas enriquecidas com proteína
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
MX2014004941A (es) Producto dietetico destinado a la prevencion del riesgo cardiometabolico.
PH12015502100A1 (en) Reducing the risk of autoimmune disease
EA201491426A1 (ru) Новые фармацевтические композиции, содержащие фосфатидилсерин и куркумин
BR112017006969A2 (pt) peptídeo derivado de hsp70, composição farmacêutica para o tratamento ou a prevenção de câncer usando o mesmo, indutor de imunidade e método de produção de célula apresentadora de antígeno
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
PH12015502037A1 (en) Activating adiponectin by casein hydrolysate
BR112017001963A2 (pt) composição farmacêutica oral, seu processo de preparação e método de tratamento
BR112018003714A8 (pt) Composições de ácido de peso aumentado que compreendem aminoácidos
GB201118201D0 (en) Novel peptides
ES2388094B1 (es) Fraccion de bajo peso molecular de un hidrolizado de lactoferrina para el tratamiento de la hipertension.
AU2017247612A9 (en) Hafnia alvei based pharmaceutical and food compositions for inducing satiation and prolonging satiety
AR092102A1 (es) Hidrolizado de proteinas
BR112017028052A2 (pt) peptídeo, método para induzir uma resposta imune em um sujeito e formulação de vacina
BR112018008964A2 (pt) método para induzir saciedade
MX2017001900A (es) Composicion nasal con capacidades de formacion de pelicula.
MX348902B (es) Métodos y composiciones adecuados para prevenir y tratar hiperleptinemia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2388094

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20130913

FA2A Application withdrawn

Effective date: 20140110